NERLYNX® (neratinib)

About Specialized Therapeutics

Specialised Therapeutics is a commercial-stage biopharmaceutical company founded in 2007, specializing in the licensing and commercialization of oncology and rare disease therapies in the Australasian and Southeast Asian markets. The company leverages deep regional expertise and a partnership-driven model, having established collaborations with 18 international biopharma companies. With a track record of successfully launching multiple products and a significant philanthropic footprint, it has emerged as the largest independent pharmaceutical company in Australia. Its leadership team comprises seasoned executives from major global pharmaceutical firms.

Therapeutic Areas

Other HER2-positive breast cancer Drugs